Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Lymphoma: Update in Hematology. (0.08 sec) 

[PDF] Update in Hematology


LGNH Lymphoma - Annals of Internal Medicine, 2002 - Am Coll Physicians
I n the past several years, there has been a veritable explosion of new and impressive treatments
that not only will alter the management of leukemia and lym- phoma but are expected to have
far-reaching effects in general internal medicine. Target-specific drugs, includ- ing ...
Related articles

Мабтера–первые моноклональные антитела в терапии неходжкинских …


АЯ Курильников - СОВРЕМЕННАЯ ОНКОЛОГИЯ, 2002 - consilium-medicum.com
В настоящее время в широкую клиническую практику вошел целый ряд противоопухолевых
препаратов, созданных с использованием последних достижений генной инженерии и гибридомной
технологии. Одними из них являются моноклональные антитела (МКА). ...
Related articles - Cached - All 4 versions

Hydroxyurea Therapy in Children Severely Affected with Sickle Cell Disease


KS Roth - Clinical Pediatrics, 1996 - cpj.sagepub.com
Page 1. http://cpj.sagepub.com Clinical Pediatrics DOI: 10.1177/000992289603501212
1996; 35; 666 Clin Pediatr (Phila) Karl S. Roth Hydroxyurea Therapy in Children
Severely Affected with Sickle Cell Disease http://cpj.sagepub ...
Related articles

[CITATION] 美罗华治疗慢性难治性 ITP


侯明 - 血栓与止血学, 2004 - scholar.ilib.cn
[1]Kappers-Klunne MC, van't Veer MB. Cyclosporin A for the treatmentof patients with chronic
idiopathic thrombocytomenic purpura refractory to cortiscosteroid or splenectomy[J]. Br J
Haematol, 2001,114:121~125. ... [10]Maloney DG, Grillo lopez AG, White CA, et al. ...
Related articles

Variable patterns of response to rituximab treatment in adults with chronic …

- hematologylibrary.org [PDF] 
R Stasi, E Stipa, V Forte, P Meo, S Amadori - Blood, 2002 - bloodjournal.hematologylibrary.org
. Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ...
Cited by 95 - Related articles - BL Direct - All 5 versions

Rituxan in the treatment of cold agglutinin disease


EJ Lee, B Kueck - Blood, 1998 - bloodjournal.hematologylibrary.org
A 75-year-old woman presented to the hospital on September 30, 1997 for weakness of 2 to
4 weeks duration. The only medical history was of hypertension treated with Aldomet (Merck
& Co, West Point, PA), which the patient still took at a dose of 250 mg orally daily. Other ...
Cited by 87 - Related articles - All 4 versions

Hydroxyurea in the treatment of sickle cell associated priapism


ALIH AL JAM'A, IA AL DABBOUS - The Journal of urology, 1998 - Elsevier
A 25-year-old unmarried Saudi man with sickle cell disease presented to the emergency room
in October 1994 with painful persistent penile erection 12 hours in duration. There were no precipitating
factors and no associated symptoms. Medical history was significant for several milder ...
Cited by 31 - Related articles - BL Direct - All 6 versions

Severe cold hemagglutinin disease (CHD) successfully treated with rituximab


M Engelhardt, A Jakob, B Ruter, M Trepel, F Hirsch, M … - Blood, 2002 - Am Soc Hematology
Autoimmune hemolytic anemia results from an IgM antibody (Ab)-red cell interaction and is referred
to as cold hemagglutinin disease (CHD). CHD is most commonly associated with infectious or
lymphoproliferative diseases but may also be coupled with malignancies or autoimmune ...
Cited by 30 - Related articles - BL Direct - All 5 versions

Chimeric monoclonal anti-CD20 antibody (rituximab)—an effective treatment for a …


H Hagberg - Cancer Immunology, Immunotherapy, 1999 - Springer
A case story is presented, describing a 46 y old man, with a relapsing hairy cell leukaemia. After
treatment with monoclonal anti CD-20 antibodies (rituximab) 375 rag/week, four times, a complete
remission was obtained which has lasted > 9 months. The rituximab treatment produced a ...
Cited by 18 - Related articles - BL Direct - All 3 versions

Safety of rituximab maintenance therapy in follicular lymphomas


P Solal-Céligny - Leukemia research, 2006 - Elsevier
The human/mouse chimeric monoclonal antibody rituximab has been used extensively in treatment
of hematologic malignancies, and its efficacy and safety are well established, both as
single-agent therapy and when used in combination with chemotherapy. ...
Cited by 14 - Related articles - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google